(VIANEWS) – Rio Tinto (RIO), United-Guardian (UG), First Merchants Corporation (FRME) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Rio Tinto (RIO) | 5.68% | 2024-01-30 15:22:36 |
| United-Guardian (UG) | 5.28% | 2024-01-16 07:44:06 |
| First Merchants Corporation (FRME) | 3.81% | 2024-01-30 11:23:07 |
| Grupo Financiero Galicia S.A. (GGAL) | 2.77% | 2024-01-30 15:14:05 |
| Radius Health (RDUS) | 2.77% | 2024-01-15 09:07:05 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Rio Tinto (RIO) – Dividend Yield: 5.68%
Rio Tinto’s last close was $71.05, 10.9% below its 52-week high of $79.74. Intraday change was -1.21%.
Rio Tinto Group engages in exploring, mining, and processing mineral resources worldwide. The company operates through Iron Ore, Aluminium, Copper, and Minerals Segments. It offers aluminum, copper, iron ore, diamonds, gold, borates, titanium dioxide, salt, silver, molybdenum, and lithium. The company also owns and operates open pit and underground mines, refineries, smelters, and concentrator facilities, as well as power stations, research, and service facilities. Rio Tinto Group was founded in 1873 and is headquartered in London, the United Kingdom.
Earnings Per Share
As for profitability, Rio Tinto has a trailing twelve months EPS of $5.27.
PE Ratio
Rio Tinto has a trailing twelve months price to earnings ratio of 13.32. Meaning, the purchaser of the share is investing $13.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.53%.
Volume
Today’s last reported volume for Rio Tinto is 2600710 which is 3.03% below its average volume of 2682240.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 9, 2023, the estimated forward annual dividend rate is 4.02 and the estimated forward annual dividend yield is 5.68%.
Yearly Top and Bottom Value
Rio Tinto’s stock is valued at $70.19 at 16:15 EST, way below its 52-week high of $79.74 and way higher than its 52-week low of $58.27.
More news about Rio Tinto.
2. United-Guardian (UG) – Dividend Yield: 5.28%
United-Guardian’s last close was $7.98, 36.21% below its 52-week high of $12.51. Intraday change was 4.31%.
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. It offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. The company's medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. The company's industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. It also conducts research and development primarily related to the development of cosmetic ingredients. The company markets its products through marketing partners, distributors, and wholesalers. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Earnings Per Share
As for profitability, United-Guardian has a trailing twelve months EPS of $0.55.
PE Ratio
United-Guardian has a trailing twelve months price to earnings ratio of 14.51. Meaning, the purchaser of the share is investing $14.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.42%.
More news about United-Guardian.
3. First Merchants Corporation (FRME) – Dividend Yield: 3.81%
First Merchants Corporation’s last close was $35.21, 19.92% below its 52-week high of $43.97. Intraday change was -0.85%.
First Merchants Corporation operates as the financial holding company for First Merchants Bank that provides community banking services. It accepts time, savings, and demand deposits; and provides consumer, commercial, agri-business, and real estate mortgage loans, as well as public finance. The company also offers personal and corporate trust; brokerage and private wealth management; and letters of credit, repurchase agreements, and other corporate services. It operates 109 banking locations in Indiana, Illinois, Ohio, and Michigan counties. The company also offers its services through electronic and mobile delivery channels. First Merchants Corporation was founded in 1893 and is headquartered in Muncie, Indiana.
Earnings Per Share
As for profitability, First Merchants Corporation has a trailing twelve months EPS of $3.73.
PE Ratio
First Merchants Corporation has a trailing twelve months price to earnings ratio of 9.36. Meaning, the purchaser of the share is investing $9.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.45%.
Yearly Top and Bottom Value
First Merchants Corporation’s stock is valued at $34.91 at 16:15 EST, way below its 52-week high of $43.97 and way above its 52-week low of $24.52.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 22.4% and a negative 16.7%, respectively.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 29, 2023, the estimated forward annual dividend rate is 1.34 and the estimated forward annual dividend yield is 3.81%.
More news about First Merchants Corporation.
4. Grupo Financiero Galicia S.A. (GGAL) – Dividend Yield: 2.77%
Grupo Financiero Galicia S.A.’s last close was $21.28, 3.18% below its 52-week high of $21.98. Intraday change was 0.47%.
Grupo Financiero Galicia S.A., a financial service holding company, provides various financial products and services to individuals and companies in Argentina. The company operates through Banks, NaranjaX, Insurance, and Other Businesses segments. The company's products and services cover savings, current, and checking accounts; personal loans; express and mortgage loans; pledge and credit card loans; credit and debit cards; and online banking services. It also offers financing products and services; consumer finance services; electronic check; global custody services; Fima funds; financial and stock market services to individuals, companies, and financial institutions; foreign trade services; and capital market and investment banking products that include debt securities, short-term securities, bills, and financial trusts. In addition, the company provides robbery, personal accident, life collective, home, life, integral pyme, pet, surety, various risks, and technical insurance products. Further, it offers private banking services to high net worth individuals; and operates digital investment platform. As of December 31, 2021, it had 312 full service banking branches; and 1,991 ATMs and self-service terminals. Grupo Financiero Galicia S.A. was founded in 1905 and is based in Buenos Aires, Argentina.
Earnings Per Share
As for profitability, Grupo Financiero Galicia S.A. has a trailing twelve months EPS of $0.46.
PE Ratio
Grupo Financiero Galicia S.A. has a trailing twelve months price to earnings ratio of 46.48. Meaning, the purchaser of the share is investing $46.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.6%.
Volume
Today’s last reported volume for Grupo Financiero Galicia S.A. is 1282080 which is 4.52% above its average volume of 1226600.
Revenue Growth
Year-on-year quarterly revenue growth grew by 42.4%, now sitting on 1.09T for the twelve trailing months.
Moving Average
Grupo Financiero Galicia S.A.’s value is way higher than its 50-day moving average of $16.79 and way above its 200-day moving average of $14.89.
Yearly Top and Bottom Value
Grupo Financiero Galicia S.A.’s stock is valued at $21.38 at 16:15 EST, below its 52-week high of $21.98 and way higher than its 52-week low of $10.02.
More news about Grupo Financiero Galicia S.A..
5. Radius Health (RDUS) – Dividend Yield: 2.77%
Radius Health’s last close was $27.11, 26.01% under its 52-week high of $36.64. Intraday change was 0.18%.
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Radius Health has a trailing twelve months EPS of $-0.92.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.83%.
Yearly Top and Bottom Value
Radius Health’s stock is valued at $27.11 at 16:15 EST, way under its 52-week high of $36.64 and way higher than its 52-week low of $22.34.
More news about Radius Health.
